Authors


Harneet Kaur, MD

Latest:

Winning the Battle: Reflections of a Psychiatrist Living With BPAD

One professional psychiatrist shares his account of living with bipolar affective disorder.


Joshua Robak, MD

Latest:

Zuranolone for the Treatment of Adults With Major Depressive Disorder

This randomized, placebo-controlled, phase 3 clinical trial showed that a 14-day treatment course of oral zuranolone 50 mg/day in MDD led to significantly greater improvements in depressive symptoms when compared with placebo.


Stefan G. Hofmann, PhD

Latest:

D-cycloserine for Anxiety Disorders: What Psychiatrists Need to Know

D-cycloserine may help patients with anxiety disorders, or it might make their anxiety worse. Find out how to use it safely.


Nour Awwad

Latest:

Shattered Self: Schizophrenia Suffering, Beyond Logic and Reason

How can looking at the suffering of patients with schizophrenia through a psychodynamic lens help clinicians develop effective interventions and treatment plans?


Andrew N. Wilner, MD, FACP, FAAN

Latest:

Exploring the Underwater World

A psychiatrist discusses his favorite hobby of scuba diving.


Jon A. Van Loon, MD

Latest:

Surviving Vaccine Hesitancy Together

What is the mindset of “anti-vaxxers,” and how can you connect with them as a clinician?


Jonathan S. Comer, PhD

Latest:

Issues in Regulating DTx

We need policies that make digital therapeutics accessible and acceptable to a broad patient audience. What barriers are there to reaching that goal?


Lisa A. Eramo, MA

Latest:

Facilitating Collections From Patients

Collecting fees is essential, but it can be uncomfortable and even difficult. What strategies can you use to ease the burden?




Rahul Biljani, MD

Latest:

Racism, Policing, and COVID-19 Disparities: We Need Action!

This moment in history cannot be lost. When you ask us if we are okay, be prepared to hear us say we are not . . . and never have been. Then be prepared to do more.


Mathijs F. G. Lucassen, PhD

Latest:

Special Considerations for SGM Youth Online

Online environments have revolutionized the lives of young SGM individuals, but also created unforeseen issues...


Britta K. Ostermeyer, MD, MBA

Latest:

Organized Psychiatry Provides Strength and Value to Mental Health Professionals

"Organized medicine and specialty organizations are key pillars of support for individual physicians that provide opportunities to advocate for more funding and resources for the medical system and education."


Amanda J. Calhoun, MD, MPH
Amanda Calhoun, MD, MPH

Latest:

A New Conference Series: Improving Black Youth Mental Health

Are you ready to discuss the Black youth crisis and the need for dynamic conversations?


Rohit Madan, MD

Latest:

Augmentation Strategies for Treatment-Resistant Depression

Given that two-thirds of patients treated for a major depressive episode will fail to achieve remission of symptoms after 2 or more treatment trials of first-line antidepressants, the probability of remission will further decrease with subsequent medication trials. Treatment strategies for patients with TRD include augmentation, where a medication is added to a current antidepressant versus switching to a different antidepressant.


Tarak Vasavada, MD

Latest:

Abstinence vs Drinking in Moderation

Which is the best recommendation for the treatment of alcohol use disorder?


Robert P. Roca, MD MPH MBA

Latest:

The Science, Ethics, and Art of Disclosing a Dementia Diagnosis

How can you communicate the diagnosis in a way that relieves suffering and helps patients and their caregivers prepare for the future?


Luca Pauselli, MD

Latest:

Mental Health Disparities Among Black Americans During the COVID-19 Pandemic

The COVID-19 pandemic has disproportionately affected people of color due to legal, social, and economic inequities.


Ren Belcher, MD

Latest:

Confidentiality Dilemmas: HIPAA, Friend or Foe?

Clinicians can ensure high-quality care by remaining informed about legal and ethical considerations in navigating patient privacy dilemmas.


Meagan Kubista, MD

Latest:

Phase 3 Trials Examine Gantenerumab for Early Alzheimer Disease

Two phase 3 trials were conducted to assess the clinical and biological effects as well as the safety of gantenerumab in individuals with mild cognitive impairment or mild dementia due to AD. Here's what you need to know.


Vaibhav A. Narayan, PhD

Latest:

Digital Health as an Enabler for Patient-Centric, Outcome-Based Care

Considering challenges and opportunities in digital health solutions for mental health care.


Jana Gutierrez, MD

Latest:

What Is Complex Posttraumatic Stress Disorder and How Does It Relate to Borderline Personality Disorder?

Whether a patient has a diagnosis of cPTSD, BPD, or some combination of both, treatment should be considered multifaceted and overlapping. Learn more in this Special Report article.


Jason L. Millman

Latest:

Lessons Learned in Disaster Mental Health: The Earthquake in Armenia and Beyond

This book provides a comprehensive overview of the most sustained comprehensive mental health recovery and research program implemented after a natural disaster.



Michel Farivar, MD

Latest:

5 Steps to Improve Outcomes in Substance Abuse in Older Patients

Addiction among older adults is associated with worse medical outcomes and increased economic burden of care. The long-term use of psychoactive substances can result in adverse neurological outcomes even at therapeutic doses.


Bethany Richards, MD

Latest:

Healing Our Patients—and Ourselves

How can offering hope for chronic illness make healing possible for us all?


William A. Myerson, PhD, MBA

Latest:

Advancing Psychoanalytic Thought

How is the Sigourney Award helping expand the boundaries of psychoanalytic thinking?


Jeremy Weleff, DO

Latest:

Artificial Creativity: Humans versus AI

What does it mean to be creative?


Neuropsychiatry Committee of the Group for Advancement of Psychiatry

Latest:

COVID-19 Brings Anosmia to the Attention of Psychiatrists

Loss of smell can be devastating for patients. How can psychiatrists deal with the associated psychological effects?


Larry Culpepper, MD, MPH

Latest:

Trauma: Understanding How it Affects a Patient and How to Help

How can we, as clinicians, understand how trauma has affected our patients and respond in the most effective way?

© 2024 MJH Life Sciences

All rights reserved.